Molecular Representations

The choice of molecular representation critically impacts model performance:

• SMILES Strings: Simplified Molecular-Input Line-Entry System provides a compact text representation. While easy to implement, invalid SMILES generations require careful handling through techniques like grammar constraints.
• Graph-Based: Directly operates on molecular graphs, where atoms are nodes and bonds are edges. Graph neural networks (GNNs) can capture local and global structural patterns essential for chemical validity.
• 3D Coordinates: Models like Euclidean neural networks generate atomic positions, enabling direct prediction of conformations and quantum properties.

Conditional Generation

Practical applications often require generating molecules with specific properties. Conditional models incorporate target constraints y during generation:

Techniques like latent space arithmetic or property classifiers enable steering generation toward desired regions of chemical space. For example, adding a solubility predictor to the loss function can bias outputs toward drug-like molecules.

Evaluation Metrics

Assessing generative models requires multiple complementary metrics:

• Validity: Percentage of generated structures that are chemically plausible (e.g., proper valency)
• Uniqueness: Fraction of novel molecules not present in training data
• Diversity: Coverage of chemical space measured by Tanimoto similarity or scaffold analysis
• Property Optimization: Success rate in meeting target property thresholds

Recent benchmarks like GuacaMol and MOSES provide standardized evaluation protocols across these dimensions, enabling fair comparison between methods.

Validity and Syntactic Correctness

Generating chemically valid molecules is non-trivial due to the combinatorial explosion of possible atomic configurations. A molecule must satisfy valency constraints, where each atom adheres to its allowed number of bonds. For example, carbon typically forms four bonds, while oxygen forms two. Violations lead to unrealistic structures. Graph-based generative models must enforce these rules explicitly through constrained sampling or post-hoc correction, but this often limits diversity or requires computationally expensive rejection sampling.

where A is the adjacency matrix and v_i is the maximum valency of atom i.

Diversity vs. Quality Trade-off

Molecular generators must balance novelty with synthetic feasibility. Models like GANs or VAEs often produce either repetitive structures or chemically unstable molecules. Reinforcement learning-based approaches optimize for specific properties but may converge to local minima, generating near-identical molecules. The Pareto front between diversity and quality remains an open challenge, particularly when optimizing multiple objectives simultaneously (e.g., binding affinity and solubility).

Computational Cost of Evaluation

Quantifying molecular properties often requires density functional theory (DFT) or molecular dynamics simulations, which are prohibitively expensive for large-scale generation. Surrogate models like graph neural networks approximate these properties but introduce prediction errors. For instance, a 0.1 eV error in DFT-based energy calculations can drastically alter molecular stability assessments.

Limited Training Data

Public datasets like ZINC or ChEMBL contain millions of compounds, but this covers only a fraction of the estimated 10⁶⁰ drug-like molecules. Sparse data for rare scaffolds or functional groups leads to poor generalization. Transfer learning from large unlabeled datasets (e.g., PubChem) helps but requires careful fine-tuning to avoid negative transfer.

Multi-Objective Optimization

Real-world molecular design requires optimizing conflicting objectives: a drug candidate must be potent, non-toxic, and synthesizable. Multi-task learning often suffers from gradient conflicts, where improving one property degrades another. Pareto-optimization techniques like NSGA-II add computational overhead and struggle with high-dimensional objective spaces.

where f_i are objective functions (e.g., logP, synthetic accessibility score) and ℳ is the space of valid molecules.

Evaluation Metrics

Standard metrics like Fréchet ChemNet Distance or internal diversity scores may not correlate with real-world utility. For example, a model might score well on novelty metrics but generate molecules with impractical ring strains or undefined stereochemistry. Developing task-specific metrics that align with experimental feasibility remains an active research area.

Variational Autoencoders (VAEs) provide a probabilistic framework for learning latent representations of molecular structures, enabling the generation of novel compounds with desired properties. Unlike deterministic autoencoders, VAEs impose a probability distribution over the latent space, typically a Gaussian, allowing for smooth interpolation and sampling of molecules.

Mathematical Foundations

The VAE objective consists of two terms: the reconstruction loss and the Kullback-Leibler (KL) divergence. Given an input molecule x and its latent representation z, the evidence lower bound (ELBO) is:

where q_ϕ(z|x) is the encoder, p_θ(x|z) is the decoder, and p(z) is the prior (usually 𝒩(0, I)). The first term encourages accurate reconstruction, while the second term regularizes the latent space.

Molecular Representation and Architecture

For molecular design, SMILES strings or molecular graphs are common input representations. When using SMILES:

• The encoder processes the string via recurrent (LSTM/GRU) or convolutional layers
• The latent space captures chemical and structural features
• The decoder generates new SMILES strings character-by-character

Graph-based VAEs instead operate directly on molecular graphs, where:

• Graph neural networks encode atom and bond features
• The latent space represents graph-level embeddings
• Decoders reconstruct adjacency matrices and node attributes

Optimization Challenges

Training VAEs for molecular generation presents unique difficulties:

The high-variance of this gradient estimator often requires techniques like:

• The reparameterization trick for continuous latent variables
• Relaxed categorical distributions for discrete molecular features
• Annealing of the KL term to prevent posterior collapse

Property Optimization

Conditional VAEs enable targeted generation by incorporating property predictions y:

Latent space arithmetic allows for:

• Interpolation between molecules with desired properties
• Constraint satisfaction through gradient-based latent optimization
• Bayesian optimization over the latent space

Practical Considerations

Successful applications require:

• Careful handling of invalid SMILES outputs via grammar constraints
• Evaluation metrics beyond reconstruction error (e.g., validity, uniqueness)
• Integration with molecular dynamics for stability verification

Generative Adversarial Networks (GANs) have emerged as a powerful framework for molecular design by learning to generate chemically valid structures through adversarial training. The core architecture consists of two competing neural networks: a generator G that produces candidate molecules, and a discriminator D that evaluates their authenticity against real molecular data.

Adversarial Training Objective

The GAN framework minimizes a minimax objective where G tries to fool D, while D aims to distinguish real from generated samples:

where x represents real molecules from the training distribution p_data, and z is random noise input to the generator. In molecular applications, G(z) typically outputs either:

• SMILES strings via recurrent architectures
• Molecular graphs using graph convolutional networks
• 3D coordinates through spatial transformers

Challenges in Chemical Space

Standard GANs face unique difficulties when applied to molecular generation:

• Validity constraints: Over 90% of randomly generated SMILES strings are syntactically invalid
• Discrete outputs: Molecular representations require specialized handling of discrete graph structures
• Multi-objective optimization: Molecules must simultaneously satisfy multiple chemical properties

Architectural Adaptations

Recent advances have developed specialized GAN variants for chemistry:

OrganizedGAN

Incorporates a chemical rule checker as a third network that penalizes invalid structures during training:

where f_valid outputs 1 for chemically valid molecules and 0 otherwise.

MolGAN

Uses a graph-based approach with:

• Generator outputs adjacency matrices and atom type vectors
• Discriminator processes molecular graphs directly
• Reinforcement learning reward for desired properties

Training Techniques

Effective training strategies for chemical GANs include:

• Curriculum learning: Gradually increase molecular complexity during training
• Wasserstein loss: Improves stability through Lipschitz constraints
• Latent space interpolation: Enables smooth transitions between molecular families

Evaluation Metrics

Quantitative assessment of chemical GANs requires specialized metrics:

Case Study: Drug Discovery

In a recent application, a GAN generated 30,000 novel kinase inhibitors with:

• 92% chemical validity rate
• 85% synthetic accessibility score
• 60% passing initial biological screening

The model successfully explored regions of chemical space not present in the training data while maintaining drug-like properties.

Flow-based generative models construct molecules by learning invertible transformations between a simple prior distribution (e.g., Gaussian) and a complex data distribution. Unlike variational autoencoders (VAEs) or generative adversarial networks (GANs), flow-based models explicitly learn the probability density function, enabling exact likelihood computation and stable training.

Mathematical Foundations

Given a molecule represented as a high-dimensional vector x, a flow-based model defines a bijective mapping f_θ from x to a latent variable z sampled from a known distribution (e.g., standard normal). The change of variables formula yields the exact log-likelihood:

Here, p_z is the prior density, and the Jacobian determinant accounts for volume changes under the transformation. The model is trained via maximum likelihood estimation (MLE), optimizing θ to maximize log p_θ(x).

Architectural Components

Key design choices in flow-based molecular generation include:

• Coupling Layers: Split the input into two parts, applying an affine transformation where parameters are predicted by a neural network conditioned on the other part. This ensures invertibility and tractable Jacobians.
• Autoregressive Flows: Model dependencies sequentially, where each dimension's transformation depends only on preceding dimensions, enabling expressive but computationally intensive flows.
• Continuous Normalizing Flows (CNFs): Use neural ordinary differential equations (ODEs) to define the transformation, allowing for flexible and reversible dynamics.

Practical Considerations

Flow-based models excel in molecular generation due to their ability to:

• Generate diverse and valid molecules by sampling from the learned latent space.
• Optimize molecular properties via gradient-based methods in latent space.
• Provide exact likelihoods for probabilistic downstream tasks.

However, challenges include computational overhead from Jacobian calculations and the need for carefully designed architectures to handle discrete molecular structures (e.g., graphs). Recent advances like GraphNVP and MoFlow address these by incorporating graph neural networks (GNNs) into the flow framework.

Case Study: MoFlow

MoFlow combines flow-based models with GNNs to generate molecular graphs. It decomposes generation into:

1. Atom feature generation via a flow model.
2. Bond generation conditioned on atom features using another flow.

The model achieves state-of-the-art performance on benchmarks like ZINC250K, demonstrating high validity and uniqueness rates (>90%).

Reinforcement learning (RL) has emerged as a powerful paradigm for molecular design by framing the generation of novel compounds as a sequential decision-making problem. The agent learns to optimize molecular properties through interactions with a simulated environment, where actions correspond to structural modifications and rewards reflect desired chemical characteristics.

Markov Decision Process Formulation

The molecular design problem is formalized as a Markov Decision Process (MDP) with:

• State space (S): The current molecular structure represented as a graph or SMILES string
• Action space (A): Valid chemical transformations (e.g., adding/removing atoms, modifying bonds)
• Transition dynamics (P): Deterministic or stochastic rules governing state transitions
• Reward function (R): Property-based scoring (e.g., drug-likeness, binding affinity, synthesizability)

Policy Gradient Methods

Policy gradient approaches directly optimize the molecular generation policy $$\pi_\theta(a|s)$$ using gradient ascent on the expected reward. The REINFORCE algorithm updates parameters via:

where $$\tau$$ represents a complete trajectory of state-action pairs and $$R(\tau)$$ is the cumulative discounted reward. Practical implementations often employ baseline subtraction to reduce variance.

Q-Learning and Actor-Critic Architectures

Value-based methods learn a Q-function estimating expected future rewards:

Deep Q-Networks (DQN) and its variants have been adapted for molecular design by discretizing the action space. Actor-critic methods combine policy gradients with learned value functions, offering improved sample efficiency through bootstrapping.

Reward Shaping and Multi-Objective Optimization

Effective reward design is critical for RL-based molecular generation. Common strategies include:

• Linear combination of property predictions: $$r(m) = \sum_i w_i p_i(m)$$
• Constraint satisfaction via penalty terms
• Pareto-optimality for multi-objective cases

Recent work employs adversarial rewards where a discriminator network provides dynamic feedback on molecular validity and desirability.

Practical Considerations

Key implementation challenges include:

• Action space design: Ensuring chemical validity while maintaining exploration
• Sample efficiency: Leveraging prior knowledge through pre-training or curriculum learning
• Credit assignment: Attributing rewards to specific structural modifications
• Exploration-exploitation tradeoff: Balancing novelty with property optimization

State-of-the-art approaches often combine RL with graph neural networks or transformer architectures to better capture molecular representations and long-range dependencies in the generation process.

Generative models have revolutionized drug discovery by enabling de novo molecular design and lead optimization at unprecedented scales. Traditional methods rely on high-throughput screening (HTS) of compound libraries, which is expensive and limited by existing chemical space. In contrast, generative models explore vast chemical spaces by learning latent representations of molecular properties and generating novel compounds with desired characteristics.

Molecular Property Optimization

Generative adversarial networks (GANs) and variational autoencoders (VAEs) optimize molecules by mapping chemical space into a continuous latent space. The objective function maximizes a weighted sum of properties:

where P_i(z) represents properties like binding affinity or solubility, w_i are weights, and the L2 regularization term ensures latent vectors remain within learned chemical space boundaries.

Conditional Generation for Target-Specific Design

Conditional architectures like cVAEs or GraphINVENT generate molecules satisfying multi-objective constraints (e.g., IC₅₀ < 100 nM, logP ∈ [1,3]). The model learns a conditional distribution p(x|y), where y encodes target properties. For graph-based generation, the likelihood of a molecular graph G is decomposed as:

Generative models have revolutionized material design by enabling the exploration of vast chemical spaces beyond human intuition. These models optimize for target properties, such as bandgap energy, mechanical strength, or catalytic activity, while adhering to constraints like synthesizability and stability. The key challenge lies in mapping from molecular or crystal structures to their properties—a task traditionally addressed by quantum mechanical simulations, which are computationally prohibitive at scale.

Physics-Informed Property Prediction

Modern approaches combine deep learning with physical priors to predict material properties. Graph neural networks (GNNs) operate on atomic connectivity, while equivariant networks preserve rotational and translational symmetry. For a crystal structure with atomic positions r_i and species z_i, the formation energy E can be modeled as:

where f_θ is a neural network parameterized by θ, and ϵ accounts for prediction error. State-of-the-art architectures like MEGNet and CGCNN incorporate many-body interactions through message passing:

where h_i^(l) are node features at layer l, e_ij encodes edge attributes (e.g., bond distance), and ϕ, ψ are learnable functions.

Generative Optimization Strategies

Conditional generative models like variational autoencoders (VAEs) and diffusion models sample structures with desired properties by learning latent representations. For a VAE, the evidence lower bound (ELBO) is:

where β controls the trade-off between reconstruction and latent space regularization. Diffusion models alternatively learn to denoise structures through a Markov chain:

Practical implementations often use SchNet or GemNet as backbone architectures due to their ability to handle 3D geometric constraints.

Multi-Objective Optimization

Pareto optimization frameworks balance competing objectives (e.g., conductivity vs. thermal stability). A common approach combines property predictors with genetic algorithms:

1. Generate candidate structures via SMILES or graph-based generators.
2. Evaluate properties using surrogate models or DFT calculations.
3. Select and mutate top candidates based on Pareto dominance.

Recent work employs gradient-based optimization in latent space, where the objective function J might include penalty terms for unrealistic structures:

Here, g_θ is the generator, P_i are property predictors, and R enforces constraints like ring strain or electronegativity balance.

Case Study: High-Entropy Alloys

In a landmark application, generative models discovered novel high-entropy alloys with superior mechanical properties. The workflow involved:

• Training a VAE on 50,000 known alloy compositions.
• Using a GNN to predict yield strength and corrosion resistance.
• Optimizing in latent space via Bayesian optimization.

The resulting CoCrFeNiMn variant exhibited a 12% increase in hardness compared to state-of-the-art baselines, later validated experimentally.

Foundations of Molecular Generation

De novo molecular generation refers to the computational design of novel molecular structures with desired properties, typically guided by deep generative models. Unlike virtual screening or optimization of existing scaffolds, this approach explores uncharted chemical space by sampling from learned distributions of molecular representations. The core challenge lies in generating synthetically accessible, stable, and property-optimized molecules while navigating the vast combinatorial space of possible structures.

Modern approaches leverage graph-based or string-based representations of molecules. Graph neural networks (GNNs) operate directly on molecular graphs, where atoms are nodes and bonds are edges. Alternatively, SMILES strings provide a sequential representation that can be processed by recurrent or transformer architectures. The choice of representation impacts both the generative process and the validity of outputs.

Architectures for Molecular Generation

Three dominant architectures have emerged for de novo generation:

• Variational Autoencoders (VAEs): Encode molecules into a continuous latent space where sampling and optimization can occur. The objective combines reconstruction loss with a KL divergence term:

where β controls the trade-off between reconstruction quality and latent space regularization.

• Generative Adversarial Networks (GANs): Employ a generator-discriminator framework where the generator produces molecular structures and the discriminator evaluates their authenticity. Conditional GAN variants incorporate property constraints through auxiliary inputs.
• Autoregressive Models: Construct molecules sequentially, atom-by-atom or token-by-token, using architectures like GRUs or transformers. These models learn the conditional probability distribution:

Molecular Validity

Validity measures whether a generated molecular structure adheres to fundamental chemical rules. A valid molecule must satisfy:

• Correct atom valences (e.g., carbon forms 4 bonds)
• Proper bond orders (single, double, triple, or aromatic)
• No disconnected fragments
• No impossible ring structures

The validity rate V is calculated as:

where N_valid is the number of chemically valid molecules and N_total is the total number generated.

Uniqueness Assessment

Uniqueness quantifies the diversity of generated molecules by comparing their structural fingerprints. The Tanimoto similarity T between two molecules i and j is:

where FP represents molecular fingerprints (e.g., ECFP4). A molecule is considered unique if T_ij < 0.4 for all pairs in the generated set.

Novelty Measurement

Novelty evaluates whether generated molecules differ from known compounds in reference databases (e.g., ChEMBL, PubChem). The novelty score η is:

where T_ref is the highest Tanimoto similarity between the generated molecule and any reference compound. Values above 0.6 typically indicate meaningful novelty.

Practical Implementation

These metrics are implemented using cheminformatics toolkits:

• RDKit for structure validation and fingerprint generation
• Tanimoto matrix computation for uniqueness analysis
• Database queries via PubChemPy for novelty assessment

For large-scale evaluation, these metrics are computed in parallel across molecular batches, with results aggregated into summary statistics. The choice of fingerprint (ECFP4 vs MACCS) and similarity threshold significantly impacts the interpretation of uniqueness and novelty.

Case Study: Benchmarking GANs vs VAEs

In comparative studies, graph-based VAEs typically achieve 85-95% validity rates, while SMILES-based GANs often struggle with 60-80% validity. However, GANs tend to produce more novel structures (η ≈ 0.7) compared to VAEs (η ≈ 0.5), highlighting the trade-off between chemical realism and exploration of novel chemical space.

Multi-Objective Optimization in Molecular Design

Generative models for molecular design often require optimizing multiple properties simultaneously, such as binding affinity, solubility, and synthetic accessibility. This is formalized as a multi-objective optimization problem:

where x represents a molecular structure, 𝒳 is the chemical space, and f_i are the objective functions. The Pareto front defines the set of optimal trade-offs between objectives—no single solution can improve one objective without degrading another.

Feasibility Constraints

Practical molecular design imposes hard constraints to ensure synthesizability and safety:

• Validity: Generated structures must obey chemical valence rules.
• Synthetic accessibility (SA): Measured via retrosynthetic complexity scores (e.g., SAscore).
• Drug-likeness: Filters like Lipinski’s Rule of Five or QED scores.

These constraints are often incorporated via penalty terms in the loss function:

Latent Space Optimization

For VAEs and other latent-based models, optimization occurs in the continuous latent space z:

1. Define a scalarized objective F(z) = ∑ w_if_i(G(z)), where G is the generator.
2. Use gradient ascent: z^t+1 = z^t + η∇_zF(z).
3. Project back to valid molecules via the decoder.

Reinforcement Learning Approaches

RL frameworks treat property optimization as a Markov Decision Process:

• State: Partial molecular graph.
• Action: Adding/removing atoms or bonds.
• Reward: Weighted sum of property improvements.

Policy gradient methods (e.g., REINFORCE) update the generator G_θ via:

Case Study: Optimizing Photovoltaic Molecules

A 2022 study used a hybrid VAE-RL model to design organic photovoltaic candidates. The model optimized for:

• Bandgap (target: 1.5–2.0 eV)
• Exciton binding energy (< 0.3 eV)
• Synthetic accessibility (SAscore < 4.5)

After 50K training steps, 23% of generated molecules met all criteria vs. 2% in random screening.

Generative models for molecular design vary significantly in architecture, each offering distinct trade-offs in expressivity, training stability, and computational efficiency. The most prominent architectures—variational autoencoders (VAEs), generative adversarial networks (GANs), autoregressive models, and normalizing flows—exhibit unique strengths and limitations in molecular generation tasks.

Variational Autoencoders (VAEs)

VAEs learn a latent space representation of molecules by optimizing the evidence lower bound (ELBO):

While VAEs efficiently handle continuous molecular representations like SMILES strings, their generated molecules often violate syntactic or semantic validity constraints. The GVAE (Grammar VAE) mitigates this by incorporating grammatical rules into the decoder, improving validity rates from ~7% to ~60% for SMILES generation.

Generative Adversarial Networks (GANs)

GANs employ a minimax game between generator G and discriminator D:

In molecular design, GANs like ORGAN demonstrate superior sample quality compared to VAEs but suffer from mode collapse—generating limited molecular diversity. Reinforcement learning-based variants (MolGAN) address this by incorporating domain-specific rewards for desired chemical properties.

Autoregressive Models

Autoregressive architectures (e.g., CharRNN, Transformer-Chem) decompose molecular generation into a sequential prediction task:

Ethical and Safety Considerations

The application of generative models in molecular design introduces ethical and safety challenges that must be addressed to prevent misuse. Unlike traditional drug discovery, AI-generated molecules may exhibit unintended toxicity, bioactivity, or environmental persistence. The dual-use dilemma is particularly acute—molecules designed for therapeutic purposes could be repurposed as biochemical weapons. To mitigate risks, frameworks like the Chemical Weapons Convention and OECD Principles on AI provide guidelines for responsible innovation.

where \( w_i \) represents weights for toxicity, bioaccumulation, and other hazard factors, and \( f_i(x) \) are measurable properties of the generated molecule \( x \).

Bias and Fairness in Molecular Generation

Generative models trained on biased datasets may perpetuate inequalities in drug accessibility. For example, overrepresentation of molecules targeting diseases prevalent in high-income countries can skew research priorities. Techniques to quantify bias include:

• Distributional divergence metrics (e.g., KL divergence between generated and ideal therapeutic distributions)
• Subgroup analysis for underrepresented disease targets

Regulatory Compliance

AI-generated molecules must comply with regulatory standards such as FDA’s 21 CFR Part 11 and EMA’s Guideline on Computerised Systems. Key requirements include:

• Auditable model architectures (e.g., differentiable molecular fingerprints)
• Explainability through attention mechanisms or SHAP values

Case Study: Toxicity Prediction with Uncertainty Quantification

Bayesian neural networks can predict toxicity while quantifying epistemic uncertainty:

where \( \theta \) represents model parameters and \( \mathcal{D} \) the training data. This approach flags high-uncertainty predictions for human review.

Technical Safeguards

Implementing technical constraints in generative architectures:

• Latent space constraints: Penalizing distances from known safe chemical subspaces
• Reinforcement learning: Reward functions incorporating synthetic accessibility (SA) scores

Stakeholder Collaboration

Effective governance requires interdisciplinary collaboration:

Generative models for molecular design present significant dual-use risks, where the same technology enabling breakthroughs in drug discovery and materials science could be repurposed to design harmful substances. The ability to rapidly generate novel molecular structures with desired properties raises concerns about the potential for misuse in creating toxins, chemical weapons, or illicit drugs.

Key Dual-Use Risks

The primary risks stem from the model's capability to optimize for toxicity, bioavailability, or other harmful properties:

• De novo design of biochemical weapons: Models trained on toxicity datasets could be fine-tuned to generate novel lethal compounds.
• Drug precursor generation: The technology could be used to design novel synthetic pathways for controlled substances.
• Evasion of detection: Models could generate compounds that bypass existing screening protocols or regulatory frameworks.

Recent studies have demonstrated these risks experimentally. For example, a 2022 study showed that commercial molecular generation software could be repurposed to design VX nerve agent analogs in under 6 hours of computation time.

Technical Mitigation Strategies

Several technical approaches can help mitigate these risks while preserving beneficial applications:

1. Property-Based Filtering

Implement real-time filters that reject molecules meeting dangerous criteria. This requires calculating multiple properties:

Where P_i represents normalized properties (toxicity, volatility, etc.) and w_i are learned weights. The model can be constrained during training:

where S(x) is the safety score and τ a threshold.

2. Differential Privacy

Incorporating differential privacy during training prevents memorization of dangerous compounds:

where C is the clipping norm and σ controls privacy guarantees.

3. Controlled Generation Architectures

Modified VAE architectures can enforce safety through latent space constraints:

where g(z) is a safety classifier in latent space. Sampling is restricted to:

Institutional Safeguards

Technical solutions alone are insufficient. Effective mitigation requires:

• Access controls: Tiered access to powerful generation models based on credentials and use-case verification
• Audit trails: Comprehensive logging of all generated compounds and associated metadata
• Ethical review boards: Mandatory review processes for research involving sensitive molecular classes

The most effective approaches combine technical constraints with institutional oversight, creating multiple redundant safeguards against misuse while preserving scientific progress.

• Deep Generative Models for 3D Linker Design - PMC — Machine learning models for molecule generation have been proposed as an alternative to human-led design and rule-based transformations. 3−5 Generative models have adopted either the SMILES string representation of molecules 6−10 or, more recently, graph representations. 11−16 Existing generative models have primarily been used in two ways.
• Practical notes on building molecular graph generative models — 1 INTRODUCTION. Molecular generative models have emerged as promising methods for exploring the chemical space through de novo molecular design. 1-16 Although molecular generative models have largely focused on string-based approaches, graph-based approaches have also emerged in the last 3 years, 10-24 including a recent approach, GraphINVENT, 25 from our group.
• PDF PRACTICAL NOTES ON BUILDING MOLECULAR GRAPH GENERATIVE MODELS - ChemRxiv — (GCNs). [23-26] GNN-based models have also shown promise in molecular design applications. [9,10,13,15,22] However, when it comes to development tools, there is a lack of practical information surrounding the construction of molecular graph generative models; for example, things like why a specific architecture/method was chosen, or if the ...
• Deep Generative Models for 3D Linker Design | Journal of Chemical ... — Rational compound design remains a challenging problem for both computational methods and medicinal chemists. Computational generative methods have begun to show promising results for the design problem. However, they have not yet used the power of three-dimensional (3D) structural information. We have developed a novel graph-based deep generative model that combines state-of-the-art machine ...
• Deep generative design with 3D pharmacophoric constraints — Introduction. Drug design optimises molecules through a multi-step, iterative process in order to achieve a desired biological response. The size of the search space 1 and discontinuous nature of the optimisation landscape 2 are two key factors contributing to the difficulty of this problem and, as a result, currently molecular design is typically led by human experts.
• (PDF) Graph Networks for Molecular Design - ResearchGate — This work is one of the first thorough graph-based molecular design studies, and illustrates how GNN-based models are promising tools for molecular discovery.
  
• Design of Organic Electronic Materials With a Goal-Directed Generative ... — Design by Generative Model. The prior network from the generative model created more than 20 million chemical structures over 40 h of model generation on a single general-purpose GPU card (NVIDIA GeForce GTX 1080). REINVENT also generated 56,290 unique chemical structures when optimizing for MPO score.
• Image-based generation for molecule design with SketchMol — Valid molecular image generation. Whether image generation models can learn the construction rules of molecules is a fundamental prerequisite for applying these models to molecular design.
• Structure-Based Drug Design with a Deep Hierarchical Generative Model ... — However, the capacity of these generative models to design wet-lab-validated and target-specific mols. with novel scaffolds has hardly been verified. We herein propose a generative deep learning (GDL) model, a distribution-learning conditional recurrent neural network (cRNN), to generate tailor-made virtual compd. libraries for given biol. targets.
• Using GNN property predictors as molecule generators — Materials and molecular generation using ML is a rapidly evolving field with a large body of recent methods including variational autoencoders 25,26,27, flow-based models 28,29, diffusion models ...

• PDF PRACTICAL NOTES ON BUILDING MOLECULAR GRAPH GENERATIVE MODELS - ChemRxiv — (GCNs). [23-26] GNN-based models have also shown promise in molecular design applications. [9,10,13,15,22] However, when it comes to development tools, there is a lack of practical information surrounding the construction of molecular graph generative models; for example, things like why a specific architecture/method was chosen, or if
• Directly optimizing for synthesizability in generative molecular design ... — 2.2.4 Goal-directed generation with synthesizability metrics. An alternative to synthesizability-constrained molecular generation is to task molecular generative models to also optimize for synthesizability metrics 33,66 in the objective function, with common ones being SA score. 2,3 Although the SA score assesses molecular complexity, it is correlated with whether AiZynth can solve a route. 2 ...
• Avogadro - Free cross-platform molecular editor - Avogadro — Cross-Platform: Molecular builder/editor for Windows, Linux, and Mac OS X. Free, Open Source: Easy to install and all source code and documentation is available to modify or extend.; International: Translations into Chinese, French, German, Italian, Russian, Spanish, and others, with more languages to come.; Intuitive: Built to work easily for students and advanced researchers both.
• Artificial Intelligence in Drug Discovery and Pharmacology — DeepChem is an open-source Python-based library that provides tools for applying deep learning to drug discovery, materials science, and quantum chemistry. It supports molecular featurization, graph convolutional models, and multitask learning, enabling rapid development of predictive models for molecular properties, bioactivity, and ADMET ...
• PDF GRAPH NETWORKS FOR MOLECULAR DESIGN - ChemRxiv — molecular generative models have compared to state-of-the-art (SOTA) methods, such that it is difficult to compare the advantages of each method. This is partly explained due to the newness of the field and, until recently, the un-availability of open-source benchmarking tools; however, with the publication of various open-source benchmarking
• Open source molecular modeling - ScienceDirect — The value of open source software in cheminformatics and molecular modeling is somewhat controversial. Unsurprisingly, those affiliated with commercial scientific software argue that traditional commercial development, with its associated support and continuous development, provides a superior value [1], while open source advocates feel the benefits outweigh the burdens [2], [3].
• Large property models: a new generative machine-learning formulation ... — Fig. 1 Comparison of the forward and inverse prediction paradigms. The forward problem (top) consists of predicting molecular properties from a molecular structure. The forward problem is mature and the input to output mapping is one-to-one for common properties (i.e., one property value per structure).The inverse problem (bottom) consists of predicting the molecular structures that are ...
• Molecule Genera,on Experience: An Open Pla5orm of Material Design for ... — domains. However, most of the existing molecular generative models are Python libraries on GitHub, that are accessible for only IT-savvy users. To %ill this gap, we newly developed a graphical user interface (GUI)-based web application of molecular generative models, "Molecule Generation Experience", that is open to the general public.
• ClickGen: Directed exploration of synthesizable chemical space via ... — Source data are available with this paper. ... an ai tool for de novo drug design. J. Chem. Inf. Model. 60 ... Seo, S., Lim, J. & Kim, W. Y. Molecular generative model via retrosynthetically ...
• NIMO: A Natural Product-Inspired Molecular Generative Model ... - MDPI — Natural products (NPs) have diverse biological activity and significant medicinal value. The structural diversity of NPs is the mainstay of drug discovery. Expanding the chemical space of NPs is an urgent need. Inspired by the concept of fragment-assembled pseudo-natural products, we developed a computational tool called NIMO, which is based on the transformer neural network model. NIMO ...

• PDF GRAPH NETWORKS FOR MOLECULAR DESIGN - ChemRxiv — 1.2 Generative models The last three years has seen a lot of work on DL-based generative models; some of this work will be summarized in the next sections. For more in-depth reviews on genera-tive models, see [23-26]. 1.2.1 String-based generative models Since 2017, extensive work has been done on string-based generative models.
• Machine Learning for Polymer Informatics | ACS In Focus — Hypothetical Molecular Design. 2.3. General Knowledge of ML Models. 2.3.1 ... Generate Hypothetical Polymer Structures with Other Generative Models. 7.3.1. Variational Autoencoder (VAE) 7.3.2. Character-Level Recurrent Neural Network (CharRNN) ... 3M Non-Tenured Faculty Award (2020), and multiple best paper awards from major conferences. He has ...
• Improving Molecule Generation and Drug Discovery with a Knowledge ... — In order to improve the process of computational drug discovery, we focus on two key aspects: (i) Improved generative models: These models are capable of learning complex distributions of molecular structures from vast datasets and generating new compounds with desired properties.By automating the molecular design process, generative models can quickly propose viable drug candidates that match ...
• Generative molecular design in low data regimes - ResearchGate — Generative machine learning models sample molecules from chemical space without the need for explicit design rules. To enable the generative design of innovative molecular entities with limited ...
• IEV2Mol: Molecular Generative Model Considering Protein-Ligand ... — Generating drug candidates with desired protein-ligand interactions is a significant challenge in structure-based drug design. In this study, a new generative model, IEV2Mol, is proposed that incorporates interaction energy vectors (IEVs) between proteins and ligands obtained from docking simulations, which quantitatively capture the strength of each interaction type, such as hydrogen bonds ...
• GEOM, energy-annotated molecular conformations for property ... - Nature — Machine learning (ML) outperforms traditional approaches in many molecular design tasks. ML models usually predict molecular properties from a 2D chemical graph or a single 3D structure, but ...
• ChemSpaceAL: An Efficient Active Learning Methodology Applied to ... — 1. Introduction. The vast majority of pharmaceutical drugs function by targeting a specific protein. 1 Virtual screening and de novo drug design are popular methods for developing effective drugs. 2 Molecular generation methods powered by generative artificial intelligence (AI) can benefit both of these strategies, and there have been numerous reports of recurrent neural networks (RNNs), 3 ...
• Bidirectional Molecule Generation with Recurrent Neural Networks — Structural uniqueness, validity, and novelty of the generated molecular graphs, these aspects constitute the primary design goal of any generative model, that is, ensuring that nonredundant, chemically valid, and novel molecules are generated. For the purpose of this study, structural novelty was defined as "not contained in the training set".
• PDF Guided diffusion for inverse molecular design - Nature — design Tomer Weiss 1 , Eduardo Mayo Yanes 2 , Sabyasachi Chakraborty 2 , Luca Cosmo 3 , Alex M. Bronstein 1 & Renana Gershoni-Poranne 2
• A pharmacophore-guided deep learning approach for bioactive molecular ... — Overview of PGMG. PGMG is a pharmacophore-guided molecular generation approach based on deep learning. The overall architecture of PGMG is illustrated in Fig. 1.The goal of PGMG is to generate ...